These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 160589)

  • 61. Flow and the inhibition of prothrombinase by antithrombin III and heparin.
    Schoen P; Lindhout T
    Blood; 1991 Jul; 78(1):118-24. PubMed ID: 2070046
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of heparin on factor XIa and plasmin.
    Rosenberg RD
    Thromb Diath Haemorrh; 1975 Feb; 33(1):51-62. PubMed ID: 235160
    [No Abstract]   [Full Text] [Related]  

  • 63. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of NaC1 on inactivation of bovine thrombin by antithrombin III in the presence of low affinity-heparin or dextran sulfate.
    Oshima G; Nagasawa K
    Thromb Res; 1986 Feb; 41(3):361-72. PubMed ID: 2422780
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site.
    Theunissen HJ; Dijkema R; Grootenhuis PD; Swinkels JC; de Poorter TL; Carati P; Visser A
    J Biol Chem; 1993 Apr; 268(12):9035-40. PubMed ID: 8473344
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Steady state relations between factors X, Xa, II, IIa, antithrombin III and alpha-2 macroglobulin in thrombosis.
    Reeve EB
    Thromb Res; 1980 Apr 1-15; 18(1-2):19-31. PubMed ID: 6157218
    [No Abstract]   [Full Text] [Related]  

  • 67. Identification of two distinct heparin cofactors in human plasma. II. Inhibition of thrombin and activated factor X.
    Briginshaw GF; Shanberge JN
    Thromb Res; 1974 Mar; 4(3):463-77. PubMed ID: 4857333
    [No Abstract]   [Full Text] [Related]  

  • 68. Antifactor Xa activity measured with amidolytic methods.
    Odegård OR; Lie M; Abildgaard U
    Haemostasis; 1976; 5(5):265-75. PubMed ID: 1017722
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
    Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
    Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Practical considerations on the measurement of low molecular weight heparin anti-Xa activity.
    Aiach M; Roncato M
    Semin Thromb Hemost; 1985 Apr; 11(2):108-11. PubMed ID: 4035362
    [No Abstract]   [Full Text] [Related]  

  • 73. Mechanisms of inhibition of platelet coagulant activity.
    Ellis V; Scully MF; Kakkar VV
    Adv Exp Med Biol; 1985; 192():373-87. PubMed ID: 2422887
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells.
    Horie S; Ishii H; Kazama M
    Thromb Res; 1990 Sep; 59(6):895-904. PubMed ID: 2175954
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
    Ellis V; Scully MF; Kakkar VV
    Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Placental protein 5 (PP5) inhibits thrombin-induced coagulation of fibrinogen.
    Meisser A; Bischof P; Bohn H
    Arch Gynecol; 1985; 236(4):197-201. PubMed ID: 4026390
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Coagulation inhibition capacities of low-molecular mass and unfractionated heparin, as determined by thrombin generation.
    Elgue G; Sanchez J; Egberg N; Olsson P
    Thromb Res; 1994 Sep; 75(5):539-49. PubMed ID: 7992254
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
    Ototani N; Kikuchi M; Yosizawa Z
    Biochem J; 1982 Jul; 205(1):23-30. PubMed ID: 7126178
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of Ca2+, phospholipid and factor V on the anti-(factor Xa) activity of heparin and its high-affinity oligosaccharides.
    Barrowcliffe TW; Havercroft SJ; Kemball-Cook G; Lindahl U
    Biochem J; 1987 Apr; 243(1):31-7. PubMed ID: 3606581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.